ZOSYN 2.25 for Intravenous Injection, ZOSYN 4.5 for Intravenous Injection and ZOSYN 4.5 for I.V. Infusion Bag (Special drug use-results survey of ZOSYN in malignant tumor except the blood-forming organ malignant tumor patients with febrile neutropenia)

Trial Profile

ZOSYN 2.25 for Intravenous Injection, ZOSYN 4.5 for Intravenous Injection and ZOSYN 4.5 for I.V. Infusion Bag (Special drug use-results survey of ZOSYN in malignant tumor except the blood-forming organ malignant tumor patients with febrile neutropenia)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Piperacillin/tazobactam (Primary)
  • Indications Febrile neutropenia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Taiho Pharmaceutical
  • Most Recent Events

    • 15 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top